16-04-25, 17:21
|
#1
|
Join Date: Feb 2011
Posts: 50,607
Thanks: 28,767
Thanked 14,428 Times in 10,234 Posts
|
MASSIVE NEW Movement of Americans Scaring Trump as He DELAYS Medicare
Watchdogs WARNING Trump is Breaking MAJOR Promise & DELAYS Medicare
Massive NEW Movement of Americans is Scaring The HELL Out of Trump
-- Fighting Oligarchy Tour continues to draw massive crowds even in states where people overwhelmingly voted for Donald Trump
Trump Business allies reeling as they realize he is CRAZIER than they thought
MSNRAW 16 APR 2025
IF YOU are seriously sick and need MEDS you shouldnt have VOTED for Trump
Donald Trump on Tuesday signed an executive order that aims to delay Medicare negotiations for a broad category of prescription drugs, handing the deep pocketed pharmaceutical industry a major win as it lobbies aggressively against efforts to rein in its pricing power.
Trumps order, titled Lowering Drug Prices by Once Again Putting Americans First, instructs Health and Human Services Secretary Robert F. Kennedy Jr. to work with Congress to modify the Medicare drug price negotiation program that was established under the Biden administration and has already yielded significant results despite pharma companies best efforts to block it in court.
Specifically, Trump calls for a four year extension of the period during which small molecule prescription drugs are exempt from price negotiations with Medicare.
Under the Inflation Reduction Act, small-molecule drugs which are typically taken in pill form and represent 90% of medications currently in circulation are not subject to the price negotiation process until at least nine years after their Food and Drug Administration approval date.
Steve Knievel, a drug policy advocate at Public Citizen, warned in a statement that by pushing back the negotiation date for many drugs, Trumps order could do the opposite of its stated goal, potentially reversing recent progress on an issue that has long plagued the United States.
Further delaying Medicare drug price negotiation would lead to higher prices for patients and taxpayers, not lower ones, said Knievel. Empowering Medicare to negotiate drug prices is the only significant legislative measure taken to address Big Pharma price gouging in the last 40 years. Now Trump proposes to undermine that singular achievement.
Extending negotiation delay periods, Knievel added, is nothing but a total capitulation to the demands of drug corporation lobbyists that want to continue to overcharge Medicare beneficiaries and taxpayers.
Trump Oligarchy Business 'allies' reeling as they realize he is CRAZIER than they thought
|
|
|